eFFECTOR Therapeutics, Inc.
USD0.00
-0.00 (-0.00%)
CEO
Davide Ruggero
IPO Date
2021-03-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.00
Prev. Close
$0.00
Day Low
$0.00
Day High
$0.00
52W Low
$0.00
52W High
$0.00
Market Cap
$0.00B
Volume
0.04M
| 4,524 |
| $0.50 |
| 11 Sept 2023 | Loewy Caroline M | director | A-Award | Acquired | 40,000 | $0.65 |
| 11 Sept 2023 | Loewy Caroline M | director | Disposed | 0 | $0.00 |
| 14 Aug 2023 | WORLAND STEPHEN T | director, officer: Chief Executive Officer | M-Exempt | Acquired | 33,799 | $0.52 |
| 14 Aug 2023 | WORLAND STEPHEN T | director, officer: Chief Executive Officer | M-Exempt | Disposed | 33,799 | $0.52 |
| 22 Jun 2023 | Klencke Barbara | director | A-Award | Acquired | 20,000 | $0.82 |
| 22 Jun 2023 | Smither John W | director | A-Award | Acquired | 20,000 | $0.82 |
| 22 Jun 2023 | Gallagher Brian M. Jr. | director | A-Award | Acquired | 20,000 | $0.82 |
| 22 Jun 2023 | Ehrlich Christopher B | director | A-Award | Acquired | 20,000 | $0.82 |